Skip to main content

Improving therapies for GI tumors

Feb. 20, 2017, 8:00 AM

The signaling protein Aurora kinase A (AURKA) is overexpressed in several cancer types and has diverse oncogenic functions, making it an attractive druggable cancer target. Wael El-Rifai, M.D., Ph.D., and colleagues are exploring a role for AURKA in upper gastrointestinal cancers, which are characterized by poor patient survival and resistance to chemotherapy.

Using in vitro and in vivo models of upper gastrointestinal cancers, the investigators found that AURKA activates EIF4E (protein translation initiation factor) and cap-dependent translation and increases levels of the cancer-associated factor c-MYC.

Targeting AURKA genetically or with the small molecule inhibitor alisertib reversed these molecular events, reduced cancer cell survival in vitro and induced in vivo tumor regression of upper gastrointestinal cancer models that are resistant to the mTOR inhibitor everolimus.

In their report in Clinical Cancer Research, the researchers propose targeting AURKA as a novel therapeutic strategy to treat tumors resistant to mTOR inhibitors and those that have activation of EIF4E and c-MYC.

This research was supported by a Research Career Scientist award from the U.S. Department of Veterans Affairs and by grants from the National Institutes of Health (CA131225, CA093999, CA095103, CA068485, DK058404).

Send suggestions for articles to highlight in Aliquots and any other feedback about the column to aliquots@vanderbilt.edu

Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more